1. BDX to present at two major healthcare conferences soon. 2. Presentations include Citi's Medtech Day and Barclays' Global Healthcare Conference. 3. Webcasts available on BD investor relations site for broader access.
The announcements reflect ongoing operations but do not project immediate financial changes.
While announcements show BD's engagement, they don't indicate specific growth or risks.
Investor sentiment may be influenced briefly, but no significant long-term effects anticipated.
FRANKLIN LAKES, N.J., Feb. 13, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences:
The live webcasts of BD's presentations can be accessed from the BD investor relations website, investors.bd.com. A replay of the events will be available on the same webpage following its conclusion.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers.
BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
Media:
Troy Kirkpatrick
VP, Public Relations
858.617.2361
tkirkpatrick@bd.com
Investors:
Adam Reiffe
Sr. Director, Investor Relations
201.847.6927
areiffe@bd.com
SOURCE BD (Becton, Dickinson and Company)